Sequencing identifies additional, though less prevalent, genes mutated in melanoma.
Large-scale sequencing of entire cancer exomes and genomes has allowed us to identify novel genes involved in tumorigenesis and to characterize the mutational process. Two recently published studies provide a clearer view of the melanoma mutational landscape. Both studies provide sweeping examinations of all coding sequences in melanoma (i.e., the exome).
Hodis and colleagues profiled a set of 15 primary melanomas, 30 metastatic melanomas, and 76 short-term melanoma cultures derived from metastatic tissue. Krauthammer et al. sequenced the exomes of 147 melanomas.
They identified novel genes (beyond NRAS, PTEN, and BRAF, already known to be mutated in melanoma): PPP6C, RAC1, SNX31, TACC1, and STK19. A mutation in RAC1 was recurrent (Pro29Ser),…
Reviewing Author
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)